Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Long-term Therapy With Deflazacort Decreases Myocardial Fibrosis In Mdx Mice|
Santo Neto H.
|Abstract:||We evaluated the effects of long-term administration of de-flazacort (DFZ) on the progression of myocardial fibrosis in mdx mice. Mdx mice (6 months old) were treated with DFZ for 15 months. Myocardial fibrosis (MF) was evaluated by histomorphometric methods, and treated and untreated mdx mice of the same age (21 months) were compared. DFZ significantly decreased MF. We conclude that long-term therapy with DFZ is effective in slowing down the progression of fibrosis in the dystrophin-deficient heart. © 2009 Wiley Periodicals, Inc.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.